PT Royal Prima Tbk (PRIM.JK)
IDR 59.0
(5.36%)
IDR 59.0
(5.36%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -4.62 Billion IDR | -113.8% |
| 2022 | 27.88 Billion IDR | -70.98% |
| 2021 | 96.08 Billion IDR | 91.2% |
| 2020 | 50.25 Billion IDR | 613.08% |
| 2019 | 7.04 Billion IDR | -68.27% |
| 2018 | 22.2 Billion IDR | -15.89% |
| 2017 | 26.4 Billion IDR | 73.36% |
| 2016 | 15.23 Billion IDR | 511.72% |
| 2015 | 2.48 Billion IDR | 173.68% |
| 2014 | -3.37 Billion IDR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -11.97 Billion IDR | -163.81% |
| 2024 Q3 | -5.13 Billion IDR | 57.11% |
| 2024 Q1 | -4.54 Billion IDR | -136.78% |
| 2023 Q4 | 12.34 Billion IDR | 399392.44% |
| 2023 FY | -3.84 Billion IDR | -113.8% |
| 2023 Q1 | -8.05 Billion IDR | -172.27% |
| 2023 Q3 | -3.09 Million IDR | 99.96% |
| 2023 Q2 | -7.01 Billion IDR | 12.98% |
| 2022 Q1 | 4.2 Billion IDR | 113.28% |
| 2022 Q3 | 5.06 Billion IDR | -32.14% |
| 2022 Q4 | 11.14 Billion IDR | 120.14% |
| 2022 FY | 27.88 Billion IDR | -70.98% |
| 2022 Q2 | 7.46 Billion IDR | 77.3% |
| 2021 FY | 96.08 Billion IDR | 91.2% |
| 2021 Q1 | 20.36 Billion IDR | -18.85% |
| 2021 Q2 | 51.8 Billion IDR | 154.33% |
| 2021 Q3 | 55.07 Billion IDR | 6.33% |
| 2021 Q4 | -31.68 Billion IDR | -157.53% |
| 2020 Q3 | 20.81 Billion IDR | 25331.04% |
| 2020 Q2 | 81.84 Million IDR | -97.65% |
| 2020 Q1 | 3.47 Billion IDR | 559.56% |
| 2020 FY | 50.25 Billion IDR | 613.08% |
| 2020 Q4 | 25.09 Billion IDR | 20.58% |
| 2019 Q1 | 3.96 Billion IDR | -11.75% |
| 2019 FY | 7.04 Billion IDR | -68.27% |
| 2019 Q4 | 527.46 Million IDR | -58.47% |
| 2019 Q3 | 1.27 Billion IDR | 49.99% |
| 2019 Q2 | 846.82 Million IDR | -78.67% |
| 2018 FY | 22.2 Billion IDR | -15.89% |
| 2018 Q1 | 6.17 Billion IDR | 159.51% |
| 2018 Q2 | 3.74 Billion IDR | -39.36% |
| 2018 Q3 | 7.79 Billion IDR | 108.19% |
| 2018 Q4 | 4.49 Billion IDR | -42.28% |
| 2017 Q1 | 9.28 Billion IDR | 0.0% |
| 2017 Q4 | -10.37 Billion IDR | -156.98% |
| 2017 Q2 | 9.28 Billion IDR | 0.0% |
| 2017 Q3 | 18.2 Billion IDR | 96.0% |
| 2017 FY | 26.4 Billion IDR | 73.36% |
| 2016 FY | 15.23 Billion IDR | 511.72% |
| 2015 FY | 2.48 Billion IDR | 173.68% |
| 2014 FY | -3.37 Billion IDR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| PT Bundamedik Tbk | 211.43 Billion IDR | 102.186% |
| PT Metro Healthcare Indonesia Tbk | -36.13 Billion IDR | 87.21% |
| PT Medikaloka Hermina Tbk | 780.69 Billion IDR | 100.592% |
| PT Mitra Keluarga Karyasehat Tbk | 1207.01 Billion IDR | 100.383% |
| PT Murni Sadar Tbk | 15.2 Billion IDR | 130.396% |
| PT Famon Awal Bros Sedaya Tbk | 204.41 Billion IDR | 102.261% |
| PT Kedoya Adyaraya Tbk | 29.49 Billion IDR | 115.669% |
| PT Sarana Meditama Metropolitan Tbk | 47.32 Billion IDR | 109.766% |
| PT Siloam International Hospitals Tbk | 1728.28 Billion IDR | 100.267% |
| PT Sejahteraraya Anugrahjaya Tbk | 106.26 Billion IDR | 104.35% |